ARCHIVES

Ruffin Sworn In As Director, NIH Minority Health Center.

This article is from The Cancer Letter archive.

Vol. 27 No. 02 | January 12, 2001

Download PDF Visit The Full Archive

Related Articles

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005

Breast Cancer Overview Correlates Incidence Increase With Other Factors

July 29, 1988

Funding Opportunities: NCI extends Deadline for Three RFAs

July 9, 1999

Gene Therapy Appears to Benefit Two Children With ADA Deficiency, Scientist Tells Writers

April 9, 1993